- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
California lawmakers are moving quickly to correct a drafting error in the Medical Marijuana Regulation and Safety Act (MMRSA), a trio of bills that will finally license and regulate commercial medical cannabis activity in the state. However, lawmakers are overlooking a serious issue in the bill that directly affects individual patient-cultivators and primary caregivers.
Americans for Safe Access (ASA), the nation’s leading medical cannabis patients’ advocacy organization, is calling on lawmakers to remove licensing requirements from the MMRSA that apply to some personal non-commercial cultivation of medical cannabis. Otherwise, the MMRSA could become an obstacle to personal cultivation – a historic cornerstone of California’s twenty-year old medical cannabis program.
Pictured: California Assembly Member Jim Wood (Dem-Santa Rosa)
The Drafting Error
The MMRSA requires commercial medical cannabis cultivators, manufacturers, retailers, and other businesses to obtain licenses from both the state and the city or county in which they operate. This dual licensing structure was designed to preserve the traditional control local governments have exercised over land use issues within their borders.
The current version includes a drafting error that would make state regulators the sole licensing authority for commercial medical cannabis cultivation in any city or county that does not have an ordinance related to cultivation before March 1, 2016. Many cities and counties responded to the inadvertent deadline by banning medical cannabis cultivation and other commercial activity related to medical cannabis. Unfortunately, some jurisdictions have overreached by also banning cultivation of medical cannabis by individual patients and primary caregivers.
This was not what lawmakers intended. Assembly Member Jim Wood (D-Santa Rosa), the author of AB 243, stated in an open letter to local lawmakers in December of 2015, that the March 1, 2016, deadline for adopting local ordinances was the result of “an inadvertent drafting error.” The Assembly Member noted this error in the Assembly Journal, the official record of the Assembly, and is already engaged in a bipartisan effort to remove the deadline. The Assembly Member concludes his letter to local lawmakers by saying, “I am confident that my colleagues and I will eliminate the March 1st deadline before it becomes a realistic problem as opposed to a theoretical concern for lawmakers.”
That process is already underway. The Senate Health Committee approved AB 21 (Wood) on Wednesday. That bill will remove the deadline language in Health and Safety Code Section 11362.777(c)(4). This is an important part of cleaning up the language of the MMRSA. Hopefully, AB 21 will help to reverse the current trend of hasty and unnecessary bans on medical cannabis activity at the city and county level. That will be good news for everyone. Local governments need time to develop and adopt reasonable licensing ordinances that protect legal patients and their communities.
The Other Problem: Licensing Thresholds
Removing the March 1st deadline is a good start, but lawmakers must also address another serious flaw in the MMRSA. Health and Safety Code Section 11362.777(g) contains language that was added to AB 243 (Wood) in the final hours of last year’s session. That unexpected language infringes on the rights of individual patients and caregivers to grow their own medicine. As adopted, the section requires a state and local license for individual patients who cultivate more than 100 square feet of medical cannabis or for primary caregivers who cultivate medical cannabis in more than 500 square feet (for up to five patients). That is not much space, especially for outdoor cultivators. The licensing requirements apply even if all of the cannabis is for the patient’s personal medical use and not for sale.
The MMRSA was never intended to regulate personal non-commercial cultivation of medical cannabis. In fact, the authors took care to be sure that the bill preserved patients’ rights under the Compassionate Use Act (CUA). However, the licensing threshold language appeared late on the afternoon of September 11, 2015, the last day of the legislative session and the deadline for passing AB 243 and the other bills that comprise the MMRSA. These licensing thresholds were not a part of the ongoing conversation with stakeholders during the session, and they were not vetted or approved by any of the legislature's policy committees that reviewed AB 243.
Requiring individual patients and caregivers to obtain local and state licenses is an unnecessary burden. Licensing is likely to be expensive and complicated. Businesses and organizations that work in the field of medical cannabis can be expected to adapt, jump over bureaucratic hurdles, and pay for the cost of licensing. Individual patients and caregivers cannot.
These thresholds will be barriers to medical cannabis patients exercising their rights under the CUA, especially some of the most vulnerable patients. Many patients grow their own medicine for economic reasons. Others cultivate a specific strain they need that is not available in the commercial marketplace. And there are still more who simply prefer to cultivate their medicine at home. We cannot know how many of these personal medical cultivators will be affected by the 100/500 square foot thresholds; but it is unfair to require them to obtain licenses, whether they are few or many.
ASA holds that the threshold for state licensing should be at the point that medical cannabis is offered for sale or exchanged for consideration. There should be no square footage threshold. In fact, including a numeric limit on the size of cultivation raises potential legal issues along with patient welfare issues. The California Supreme Court held in People v. Kelly (2010) that numeric limits on how many plants patients can cultivate and on how much medicine they can possess, which were adopted by the legislature in the Medical Marijuana Program Act (MMPA) in 2003, were unconstitutional legislative amendments to a voter imitative. The same principle might apply to numeric limits on square footage. The courts could sort that out, but a legal battle is likely to be long and expensive. That is not optimal for patients, caregivers, or regulators; all of whom would benefit from clarity now.
There is a simple solution. ASA suggests striking the 100/500 square foot thresholds from Section 11362.777(g), but maintaining the requirement that cultivation exempt from licensing be strictly non-commercial. This easy fix would remove the need for individual patients and caregivers to obtain a state license, but does not infringe in any way on the authority of cities and counties to address legitimate land use and public safety issues in neighborhoods:
(g) This section does not apply to a qualified patient cultivating marijuana pursuant to Section 11362.5 if the area he or she uses to cultivate marijuana does not exceed 100 square feet and he or she cultivates marijuana for his or her personal medical use and does not sell, distribute, donate, or provide marijuana to any other person or entity. This section does not apply to a primary caregiver cultivating marijuana pursuant to Section 11362.5 if the area he or she uses to cultivate marijuana does not exceed 500 square feet and he or she cultivates marijuana exclusively for the personal medical use of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 and does not receive remuneration for these activities, except for compensation provided in full compliance with subdivision (c) of Section 11362.765…
ASA needs the help of medical cannabis advocates to persuade California lawmakers to adopt this simple fix and protect individual patient cultivation. Sign our petition calling for an amendment to Section 1362.777(g), and then share the link with others who care about medical cannabis:
ASA will be using this petition as part of our efforts to change the law beginning immediately, so don’t wait to sign and share it. Thanks for helping!